AIP-303

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameAIP-303
Drug Alias NameAIP-303
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIonising radiation emittersReceptor protein-tyrosine kinase erbB-2 modulators
TargetsReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth AfricaIndia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAdvanced Imaging Projects
China Registration ClassN/A

Develop Information

Active CompaniesAdvanced Imaging Projects
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A